Expanded Access to the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with RAF-Altered, Relapsed or Refractory Low-Grade Glioma
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of Kathleen Dorris](https://som.ucdenver.edu/FIMS/Content/faculty/21799/CU-Doctors-21799.jpg)
Kathleen Dorris
Study ID
Protocol Number: 22-2288
More information available at ClinicalTrials.gov: NCT05760586
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers